JIADE Ltd prices up to $12M offering, reinforcing dilution fears

What happened

JIADE Ltd (JDZG) announced a registered direct offering of up to $12 million of Class A ordinary shares, per a May 4, 2026 press release. This comes on the heels of a DeepValue master report that flagged the company's reliance on equity financing at sub-$1 prices, negative operating cash flow, and a potential sell rating. The offering aligns with the report's bear scenario, which warned that capital availability would remain equity-only given constrained PRC cash upstreaming and negative OCF. With prior offerings priced at $0.58 and similar terms likely here, the new shares will further dilute existing holders, compounding per-share value erosion. The company's fundamentals—weak pricing power, extreme customer concentration, and a material weakness in controls—remain unsupportive of the current market price.

Implication

This $12M registered direct offering is a critical negative signal that validates the DeepValue report's bearish thesis. JDZG's history of selling shares at $0.58 and now pursuing another large equity raise demonstrates that its negative operating cash flow (RMB -5.1M in FY2024) forces repeated reliance on dilutive capital. With operating cash flow unlikely to turn positive before FY2026, further issuances are probable. The attractive entry price of $2.25 from the report now looks even more distant, while the ceiling of $3.70 in the base scenario is at risk. Investors should exit or reduce positions aggressively, as the probability of sustained sub-$1 trading and additional reverse splits has increased. The only potential catalyst for a re-rating is a sudden positive operating cash flow surprise in the next 6-K, but past performance offers no reason to expect that.

Thesis delta

The news triggers the 'decreases if' condition from the DeepValue report: a new SEC filing pricing shares at or near $0.58, confirming the dilution cycle. The bear scenario (45% probability, $2.20 target) now becomes the base case, as the company's funding model is structurally dependent on discounted equity offerings. The bull case ($6.50) is now less likely (<10%) given the continued reliance on external capital rather than self-funded growth. The investment thesis shifts from 'wait and see' to 'exit or reduce' until demonstrable improvement in operating cash flow appears.